Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|June 29, 2014
Influence of azide incorporation on binding affinity by small papain inhibitorsAngelique E M Wammes, Tom G Hendriks, Helene I V Amatdjais-Groenen, et al.
Bioconjugate Chemistry|December 27, 2021
Strain-Promoted Azide-Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate CancerYvonne H W Derks, Mark Rijpkema, Helene I V Amatdjais-Groenen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 14, 2022
Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancerYvonne H W Derks, Sanne A M van Lith, Helene I V Amatdjais-Groenen, et al.
Chembiochem : a European Journal of Chemical Biology|May 23, 2012
Papain-specific activating esters in aqueous dipeptide synthesisRoseri J A C de Beer, Barbara Zarzycka, Michiel Mariman, et al.
Chembiochem : a European Journal of Chemical Biology|August 10, 2011
Papain-catalyzed peptide bond formation: enzyme-specific activation with guanidinophenyl estersRoseri J A C de Beer, Barbara Zarzycka, Helene I V Amatdjais-Groenen, et al.
Theranostics|January 7, 2021
Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancerYvonne H W Derks, Mark Rijpkema, Helene I V Amatdjais-Groenen, et al.
Scientific Reports|March 1, 2020
Examining sterically demanding lysine analogs for histone lysine methyltransferase catalysisAbbas H K Al Temimi, Vu Tran, Ruben S Teeuwen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2023
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligandYvonne H W Derks, Melline G M Schilham, Mark Rijpkema, et al.
Pageof 2